President and Chief Executive Officer
VP, Regulatory Affairs
VP, Market Development
Tim Fischell, MD, FACC
Chief Medical Officer
VP, R&D and Operations
Board of Directors
Michael Fulton, MD
Senior Managing Director, BioStar Capital
Chairman of the Board
General Manager – TMVR, LivaNova PLC
David Fischell, PhD
Chairman and CEO, Angel Medical Systems
Dr. Fischell has received numerous awards and recognitions including his 1990 award for his design of the architecture of the AT&T network platform for enhanced voice services and election as a Fellow of the American Institute for Medical and Biological Engineering. He was elected to the Cornell University Board of Trustees in 2008 and the Weill Cornell Medicine Board of Overseers in 2016. He holds an appointment as adjunct professor, is chairman of the Advisory Council and was instrumental in the founding in 2004 of Cornell's Meing School of Biomedical Engineering.
President and Managing Partner, Charter Capital Partners
John is general partner and actively manages various investment funds including Charter Growth Capital Fund, a mezzanine debt and minority equity fund, Michigan Accelerator Fund I, an early stage VC fund as well as multiple other private equity investment entities.
He is a current board member for Keystone Solutions, RimGuard, Ablative Solutions and Hastings Mutual Insurance Company and a board observer for Trice Medical and Swift Biosciences. John is a past board member for Grand River Aseptic Manufacturing, Intervention Insights, the Michigan Medical Device Accelerator and the national board for the Association for Corporate Growth.
John has attained FINRA securities registrations including the Series 79, 62, 63 and 65, and earned the Certified Valuation Analyst designation from the National Association of Certified Valuators and Analysts. He has a BA from Michigan State University and an MBA from DePaul University.
Partner, Gilde Healthcare
Mr. Pardo also served as President & CEO of Facet Solutions, a spinal implant company focused on treating lumbar spinal stenosis until the company was sold to Globus Medical in 2011. Mr. Pardo began his career in medical devices as a product manager with Synthes USA (now J&J Depuy Synthes). Geoff has a B.A. from Brown University and an M.B.A. from the Wharton School of Business.
President and Chief Executive Officer
Coronary Segment Leader, Philips - San Diego, CA
Andrew has had roles in quality engineering, product development, clinical research, marketing & sales during his 18 year career in Cardiovascular Medical Devices. He has a Bachelors of Science in Chemical Engineering from Rose-Hulman Institute of Technology in Terre Haute, IN, and a Masters of Business Administration from the Wharton School of Business, University of Pennsylvania.
President and CEO of Bache, Inc
Prior to joining AqueSys, Bache was a Global Vice President at Advanced Medical Optics, the spinout of Allergan Surgical, and is now Johnson & Johnson Vision. Bache had marketing responsibility for the global refractive surgery business which included excimer lasers, custom wavefront guided and standard LASIK procedures, femtosecond lasers, wavefront abberrometers, multifocal intraocular lenses, phakic intraocular lenses, corneal inlays, and mechanical microkeratomes. During his tenure, AMO became the world’s #1 refractive surgery company through approximately $2 billion in acquisitions, partnerships, and internal R&D. Prior to AMO, Bache held commercial positions at Kraft General Foods, Johnson & Johnson (IOLAB Pharmaceuticals), Novartis (CIBA Ophthalmics), and Allergan Surgical.
Bache earned his Bachelor of Science in Business Administration from the University of Southern California and has completed executive education programs at Stanford and Harvard Business School.
We are proud to work with some of the most committed innovators in the industry.
Scientific Advisory Board (Global)
Gregg W. Stone, MD, FACC, FSCAI
Chairman of Publication Committee, Director of Cardiovascular Research and Education, Columbia University Medical Center / New York-Presbyterian Hospital
Prof. Melvin Lobo
Director, Barts Blood Pressure Centre of Excellence, London, UK
David E. Kandzari, MD
Director, Interventional Cardiology and Chief Scientific Officer, Piedmont Heart Institute, Atlanta, Georgia
Prof. Dr. med. Alexandre Persu
Head of the Hypertension Clinic Cardiology Department. Cliniques Universitaires Saint-Luc Université, Brussels, Belgium
Prof. Dr. med. Felix Mahfoud
Department of Internal Medicine and Cardiology, University Hospital of the Saarland, Germany
Prof. Atul Pathak
Head of Clinical Research, Hypertension, Heart Failure Clinic, Clinique Pasteur, Toulouse, France
Prof. Dr. med. Roland E. Schmieder
Head of the Clinical Research Center (CRC), University Hospital Erlangen, Germany
Michael Weber, MD, FACP, FACC, FAHA
Professor of Medicine at SUNY Downstate College of Medicine, Brooklyn, NY